As a result, the serum levels of IL1B, IL6, CXCL8, TNFA and CCL2 were significantly up-regulated in colorectal cancer patients, compared with those in healthy controls, while there is no difference for IL10 between two groups (Fig. 2A). Here, CCL2 is linked to colorectal cancer.